Skip to content

The influence of cytokine biomarkers on sciatica

The Influence of cytokine biomarkers on sciatica: a nested study within the ATLAS cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN24557732
Enrollment
120
Registered
2012-10-09
Start date
2012-06-07
Completion date
Unknown
Last updated
2018-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica Musculoskeletal Diseases Sciatica

Interventions

We aim to recruit 120 participants from patients attending ATLAS clinics. As part of the ATLAS clinic, the patients are assessed by a physiotherapist who will determine if they have a radiculopathy (s

Sponsors

Keele University (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study is nested within a larger cohort study (ATLAS study) and patients for this study will be recruited from the ATLAS cohort. Hence the principal inclusion criteria is: 1. Adults aged 18 years and over who are attending an ATLAS clinic because they have consulted their GP with low back 2. Leg pain of any duration and who consent and are eligible to take part in the ATLAS study 3. Male & female participants

Exclusion criteria

Exclusion criteria: Ineligibility and/or not consenting to take part in the ATLAS study. All participants for this study will be recruited from the ATLAS study hence the exclusion criteria to take part in this study are the same as the exclusion criteria for the ATLAS study: 1. Persons with signs and symptoms indicative of possible serious spinal pathology 2. Serious comorbidity which stop patients from being able to undergo the assessment 3. Patients with serious mental health problems who are vulnerable and for whom participation in the study would be detrimental (at the GP?s discretion) 4. Previous spinal surgery 5. Pregnancy 6. Currently receiving physiotherapy (or osteopathy, chiropractic) or under a secondary care consultant for the same problem 7. Not able to read and speak English

Design outcomes

Primary

MeasureTime frame
Median cytokine levels compared across the 3 study groups measured at baseline

Secondary

MeasureTime frame
1. Comparing cytokine levels with baseline 2. Pain intensity, pain severity and pain duration measured at baseline

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026